Splenic metabolic activity as biomarker in cervical cancer

E.A. De Jaeghere , F. Laloo , L. Lippens , K. De Man
Annals of Oncology 30 ( 5)

1
2019
Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European survey

Giancarlo Marra , Guillaume Ploussard , Piet Ost , Pieter JL De Visschere
Urologic Oncology-seminars and Original Investigations 36 ( 12) 1 -12

16
2018
AN INTERNATIONAL SURVEY ABOUT FOCAL THERAPY FOR PROSTATE CANCER FROM THE YOUNG ACADEMIC UROLOGISTS (YAU): THE OPINION OF 484 PHYSICIANS

Marra Giancarlo , Guillaume Ploussard , Piet Ost , Pieter JL De Visschere
ANTICANCER RESEARCH 38 ( 4) 2567 -2568

2018
Performance of MRI for Detection of≥ pT1b Disease in Local Staging of Endometrial Cancer

Leonie Van Vynckt , Philippe Tummers , Hannelore Denys , Menekse Göker
Cancers 16 ( 6) 1142 -1142

2024
ATTRACTIVENESS AND ACCESSIBILITY OF FOCAL THERAPY FOR PROSTATE CANCER: RESULTS OF AN INTERNATIONAL WEB-BASED SURVEY: PD34-10

Giancarlo Marra , Guillaume Ploussard , Piet Ost , Pieter JL De Visschere
Journal of Urology 199 ( 4) e659 -e660

2018
A systematic review on the role of imaging in early recurrent prostate cancer

Pieter JL De Visschere , Chloë Standaert , Jurgen J Fütterer , Geert M Villeirs

177
Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review

Alexander Kretschmer , Guillaume Ploussard , Isabel Heidegger , Igor Tsaur
European Urology Focus

22
2020
Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now?

Igor Tsaur , Isabel Heidegger , Alexander Kretschmer , Hendrik Borgmann
Cancer Treatment Reviews 75 20 -26

11
2019
Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?

Guillaume Ploussard , , Hendrik Borgmann , Alberto Briganti
World Journal of Urology 37 ( 2) 243 -251

23
2019
MP79-01 EXTERNAL VALIDATION OF THE 2019 BRIGANTI NOMOGRAM FOR THE IDENTIFICATION OF PROSTATE CANCER PATIENTS WHO SHOULD BE CONSIDERED FOR AN EXTENDED PELVIC LYMPH NODE DISSECTION

Giorgio Gandaglia* , Alberto Martini , Guillaume Ploussard , Pieter de Visschere
The Journal of Urology 203 ( Supplement 4) e1215 -e1215

2020
The Influence of Anthropometric Factors on Renal mpMRI: Insights From Regional Analysis

Luis Carlos Sanmiguel Serpa , Pieter de Visschere , Marijn Speeckaert , Pim Pullens
Journal of magnetic resonance imaging: JMRI

Role of MRI in follow-up after focal therapy for prostate carcinoma.

Pieter J. De Visschere , Gert O. De Meerleer , Jurgen J. Fütterer , Geert M. Villeirs
American Journal of Roentgenology 194 ( 6) 1427 -1433

74
2010
Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients.

Geert M. Villeirs , Gert O. De Meerleer , Pieter J. De Visschere , Valerie H. Fonteyne
European Journal of Radiology 77 ( 2) 340 -345

101
2011
Comparison of qualitative and quantitative approach to prostate MR spectroscopy in peripheral zone cancer detection.

Stijn Klijn , Pieter J. De Visschere , Gert O. De Meerleer , Geert M. Villeirs
European Journal of Radiology 81 ( 3) 411 -416

12
2012
Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

Emiel A. De Jaeghere , Frederiek Laloo , Lien Lippens , Mieke Van Bockstal
Gynecologic Oncology 159 ( 2) 335 -343

2
2020
Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey.

Cristian I. Surcel , Prasanna Sooriakumaran , Alberto Briganti , Pieter J.L. De Visschere
BJUI 115 ( 4) 571 -579

25
2015
Post-treatment complications of soft tissue tumours

L.G. Shapeero , P.J.L. De Visschere , K.L. Verstraete , B. Poffyn
European Journal of Radiology 69 ( 2) 209 -221

30
2009